Search
Search site

Current Patent Journal

Publication of patent applications and events is undertaken by the Intellectual Property Office once a week. New notices are posted on the site every Monday and will remain published for 20 working days. Notices are also archived as appropriate every Monday.

Date of Journal: 27/01/2020

 
Date PublishedDate of Application in BailiwickPatent TitleField of InventionRegistered ProprietorOverseas Registration, Jurisdiction, Number & Link to WebBailiwick Registered AgentSupporting Documents
13/01/2003/01/205-phenoxy-3H-pyrimidin-4-one derivatives and their uses as HIV reverse transcriptase inhibitorsC07D401/14; C07D239/56; C07D403/06; C07D403/14; C07D471/04; C07D239/52; C07D239/54; A61K31/513; A61P31/18Merck Sharp & Dohme Corp.

European Patent Office

EP2903977

David Evans (Collas Crill)-
13/01/2007/01/20Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of useC07K 16/00; C12P 21/08; A61K 39/085; A61K 39/40; C07K 16/12MedImmune, LLC

European Patent Office

EP2673373

David Evans

(Collas Crill)

-
13/01/2009/01/20Polycyclic amide derivatives as CDK9 inhibitorsC07D 471/04; C07D 487/04; C07D 498/04; A61K 31/437; A61P 35/00AstraZeneca AB

European Patent Office

EP3313838

David Evans

(Collas Crill)

-
20/01/2013/01/20Macrocyclic derivatives for the treatment of proliferative diseasesC07D 491/08 (2006.01) C07D 491/18 (2006.01) C07D 498/08 (2006.01) C07D 498/18 (2006.01)C07D 498/22 (2006.01) C07D 513/18 (2006.01) A61K 31/4353 (2006.01) A61P 35/00 (2006.01)Pfizer Inc.

European Patent Office

EP2822953

David Evans

(Collas Crill)

-
27/01/2022/01/20Methods for increasing forced expiratory volume in asthmatics using benralizumabA61K 39/00; A61K 39/395; G01N 33/48AstraZeneca AB

European Patent Office

EP3033104

David Evans

(Collas Crill)

-